Related Experiment Video
Updated: May 30, 2026
05:33
Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting
Published on: August 4, 2023
Intractable nausea caused by zolpidem withdrawal: a case report
Edward Baruch1, Leonard F Vernon, Rafael J Hasbun
1Departments of Psychiatry, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.
Journal of Addiction Medicine
|July 20, 2011
Summary
Zolpidem (Ambien®) may cause dependency and withdrawal symptoms like severe nausea, contradicting earlier beliefs of low risk. Patient education on potential dependency and discontinuation is crucial to prevent misdiagnosis.
Area of Science:
- Pharmacology
- Clinical Medicine
Background:
- Zolpidem (Ambien®), a short-acting hypnotic, was initially believed to have a low risk of dependence compared to benzodiazepines.
- Manufacturer marketing and physician education have emphasized zolpidem's safety and efficacy, potentially overshadowing risks.
Purpose of the Study:
- To highlight the underrecognized risk of zolpidem dependency and withdrawal.
- To report a case of severe zolpidem withdrawal presenting as intractable nausea.
Main Methods:
- Case report of a 41-year-old female experiencing zolpidem dependency.
- Analysis of reported zolpidem withdrawal cases and associated symptoms.
Main Results:
- The case study details a patient developing severe withdrawal symptoms, including intractable nausea, after reducing a relatively low dose of zolpidem.
- This presentation of nausea as the sole severe symptom is unique among reported zolpidem withdrawal cases.
Conclusions:
- Zolpidem dependency and withdrawal are significant clinical concerns that may be underestimated.
- Comprehensive patient education regarding zolpidem's potential for dependency and risks of abrupt discontinuation is essential for preventing adverse events and misdiagnosis.
More Related Videos
Related Concept Videos
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...